CIPAST Newsletter October 2005
The quarterly CIPAST newsletter is the additional information tool to the CIPAST Discussion list and the Forum Debate with its brief information and ongoing discussion with reports and articles that represent the current situation of participatory procedures in Europe.Please find below the contributions to this first issue of the CIPAST newsletter.
The next issue will be published in January 2006. Please feel free to contribute.
Table of Contents
Partnerships and Public Participation
CIPAST: Transfer of expertise and training activities
The regulation of scientific-technological innovation becomes More and more hazardous for decision makers. Taking genetic modified organisms, nanotechnology or intensive care medicine as examples: Will the political, economic or social consequences of todays decisions be justified in 10 or 20 years? What if the decisions have been wrong? >>more
Project to engage the public in a debate on nanotechnologies and nanosciences
The development of nanotechnologies and nanosciences (N&N) is still at an early stage, but the market for nanotechnology-based products is expected to rise to hundreds of billions of euro by 2010. NanoDialogue is a recently launched project to foster public debate on the developments of research in this field. >>more
Europe-wide dialogue launched on benefits, risks and social, ethical and legal implications of nanotechnologies
Nanologue, an European Commission-funded project, was launched in February 2005, bringing together leading researchers from across Europe to facilitate an international dialogue on the social, ethical and legal benefits and potential impacts of nanoscience and nanotechnologies. >>more
A democratic tool to influence how new technologies are developed
A citizens' jury is like a legal jury in that they will give a 'verdict' after being presented with information and perspectives from a range of different witnesses. The NanoJury UK brought together twenty randomly-chosen people from different backgrounds who heard evidence about a wide range of possible futures, and the role that nanotechnologies might play in them. >>more
Meeting of Minds
European Citizens’ Deliberation on Brain Science
Meeting of Minds is a two-year pilot project led by a European panel of 126 citizens. A consortium of technology assessment bodies, science museums, academic institutions and public foundations from nine European countries launched this initiative in 2004 with the support of the European Commission. It will give European citizens a unique opportunity to learn more about the impact of brain research on their daily lives and society as a whole and discuss their questions and ideas with leading European researchers. >>more
Debates about risk are important. But the public also want answers to the more fundamental questions at stake in any new technology. Spurred on by high profile controversies over BSE, GM crops and now nanotechnology, scientists have gradually started to involve the public in their work. In ‘See-through Science’, James Wilsdon and Rebecca Willis from ‘Demos’ – an organisation which explains itself as a think tank for everyday democracy – argue that we are on the cusp of a new phase in debates over science and society: Public engagement is about to move upstream. This publication offers practical guidance for scientists, policymakers, research councils businesses and NGOs – anyone who is trying to make engagement work. See http://www.demos.co.uk for more details or download a pdf copy here.
The views expressed in the notes, messages and links are those of the authors and owners of the website and are not necessarily endorsed by the publisher. Whilst every care has been taken, the publisher does not accept any liability for errors that may have occurred.
If you want to subscribe for the newsletter, please send a short message to firstname.lastname@example.org (online subscription will be available soon). You can find the archive of the newsletter here: (link: Forum/newsletter/archive)
Please recommend this newsletter to your colleagues and partners.
This is your site!
Website, forum and newsletter live from your participation: So please feel free to criticise, prompt and contribute news, events, short reports or experiences from your special field of work (email@example.com).